메뉴 건너뛰기




Volumn 22, Issue 1, 2013, Pages 70-76

Patients' motives for participating in active post-marketing surveillance

Author keywords

Adverse drug reaction; Intensive monitoring; Motivation; Patient; Pharmacoepidemiology; Pharmacovigilance; Web

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; DESCRIPTIVE RESEARCH; FEMALE; GENDER; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT PARTICIPATION; PERSONAL EXPERIENCE; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; QUESTIONNAIRE;

EID: 84872137143     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3327     Document Type: Article
Times cited : (26)

References (21)
  • 1
    • 43749091268 scopus 로고    scopus 로고
    • Adverse drug reaction reporting by patients in the Netherlands: three years of experience
    • de Langen J, van Hunsel F, Passier A, et al. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf 2008; 31(6): 515-24.
    • (2008) Drug Saf , vol.31 , Issue.6 , pp. 515-524
    • de Langen, J.1    van Hunsel, F.2    Passier, A.3
  • 2
    • 70349970392 scopus 로고    scopus 로고
    • Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006
    • DOI: 10.2165/11316680-000000000-00000
    • Aagaard L, Nielsen LH, Hansen EH. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Saf 2009; 32(11): 1067-74. DOI: 10.2165/11316680-000000000-00000
    • (2009) Drug Saf , vol.32 , Issue.11 , pp. 1067-1074
    • Aagaard, L.1    Nielsen, L.H.2    Hansen, E.H.3
  • 3
    • 77955570230 scopus 로고    scopus 로고
    • Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals
    • DOI: 10.2165/11536510-000000000-00000
    • McLernon DJ, Bond CM, Hannaford PC, et al. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals. Drug Saf 2010; 33(9): 775-88. DOI: 10.2165/11536510-000000000-00000
    • (2010) Drug Saf , vol.33 , Issue.9 , pp. 775-788
    • McLernon, D.J.1    Bond, C.M.2    Hannaford, P.C.3
  • 4
    • 79951986271 scopus 로고    scopus 로고
    • The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study
    • DOI: 10.1002/pds.2092
    • van Hunsel F, Talsma A, van Puijenbroek E, et al. The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study. Pharmacoepidemiol Drug Saf 2011; 20(3): 286-91. DOI: 10.1002/pds.2092
    • (2011) Pharmacoepidemiol Drug Saf , vol.20 , Issue.3 , pp. 286-291
    • van Hunsel, F.1    Talsma, A.2    van Puijenbroek, E.3
  • 5
    • 77949407113 scopus 로고    scopus 로고
    • The missing voice of patients in drug-safety reporting
    • Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med 2010; 362(10): 865-9.
    • (2010) N Engl J Med , vol.362 , Issue.10 , pp. 865-869
    • Basch, E.1
  • 6
    • 80053917697 scopus 로고    scopus 로고
    • The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective
    • DOI 10.1111/j.1365-2125.2011.03990.x
    • Anderson C, Krska J, Murphy E, et al. The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol 2011; 72(5): 806-22. DOI 10.1111/j.1365-2125.2011.03990.x
    • (2011) Br J Clin Pharmacol , vol.72 , Issue.5 , pp. 806-822
    • Anderson, C.1    Krska, J.2    Murphy, E.3
  • 7
    • 84872156028 scopus 로고    scopus 로고
    • Directive 2010/84/EU. Official Journal of the European Union. Dec 31;L. 348-74-99.
    • Directive 2010/84/EU. Official Journal of the European Union 2010. Dec 31;L. 348-74-99.
    • (2010)
  • 8
    • 84872148824 scopus 로고    scopus 로고
    • Regulation 1235/2010. Official Journal of the European Union 10 A.D. Dec 31;L. 348-1-16.
    • Regulation 1235/2010. Official Journal of the European Union 10 A.D. 2010. Dec 31;L. 348-1-16.
    • (2010)
  • 9
    • 79955140231 scopus 로고    scopus 로고
    • Getting to grips with the new European Union pharmacovigilance legislation
    • DOI: 10.1002/pds.2119
    • Waller P. Getting to grips with the new European Union pharmacovigilance legislation. Pharmacoepidemiol Drug Saf 2011; 20(5): 544-9. DOI: 10.1002/pds.2119
    • (2011) Pharmacoepidemiol Drug Saf , vol.20 , Issue.5 , pp. 544-549
    • Waller, P.1
  • 10
    • 79951788370 scopus 로고    scopus 로고
    • Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance
    • DOI: 10.2165/11586620-000000000-00000
    • Borg JJ, Aislaitner G, Pirozynski M, et al. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance. Drug Saf 2011; 34(3): 187-97. DOI: 10.2165/11586620-000000000-00000
    • (2011) Drug Saf , vol.34 , Issue.3 , pp. 187-197
    • Borg, J.J.1    Aislaitner, G.2    Pirozynski, M.3
  • 11
    • 79951822353 scopus 로고    scopus 로고
    • Intensive Monitoring of Pregabalin Results from an Observational, Web-Based, Prospective Cohort Study Using Patients as a Source of Information
    • DOI: 10.2165/11585030-000000000-00000
    • Härmark L, van Puijenbroek E, Straus S, et al. Intensive Monitoring of Pregabalin Results from an Observational, Web-Based, Prospective Cohort Study Using Patients as a Source of Information. Drug Saf 2011; 34(3): 221-31. DOI: 10.2165/11585030-000000000-00000
    • (2011) Drug Saf , vol.34 , Issue.3 , pp. 221-231
    • Härmark, L.1    van Puijenbroek, E.2    Straus, S.3
  • 12
    • 79959543811 scopus 로고    scopus 로고
    • Longitudinal monitoring of the safety of drugs by using a web-based system: the case of pregabalin
    • DOI: 10.1002/pds.2135
    • Härmark L, van Puijenbroek E, van Grootheest K. Longitudinal monitoring of the safety of drugs by using a web-based system: the case of pregabalin. Pharmacoepidemiol Drug Saf 2011; 20(6): 591-7. DOI: 10.1002/pds.2135
    • (2011) Pharmacoepidemiol Drug Saf , vol.20 , Issue.6 , pp. 591-597
    • Härmark, L.1    van Puijenbroek, E.2    van Grootheest, K.3
  • 13
    • 84555190232 scopus 로고    scopus 로고
    • Web-based Intensive Monitoring, from passive to active drug surveillance
    • Härmark L, van Grootheest AC. Web-based Intensive Monitoring, from passive to active drug surveillance. Expert Opin Drug Saf 2012; 11(1): 45-51.
    • (2012) Expert Opin Drug Saf , vol.11 , Issue.1 , pp. 45-51
    • Härmark, L.1    van Grootheest, A.C.2
  • 14
    • 78649316137 scopus 로고    scopus 로고
    • Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
    • van Hunsel F, van der Welle C, Passier A, et al. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands. Eur J Clin Pharmacol 2010; 66(11): 1143-50.
    • (2010) Eur J Clin Pharmacol , vol.66 , Issue.11 , pp. 1143-1150
    • van Hunsel, F.1    van der Welle, C.2    Passier, A.3
  • 15
    • 34447104848 scopus 로고    scopus 로고
    • Why, and how, mixed methods research is undertaken in health services research in England: a mixed methods study
    • O'Cathain A, Murphy E, Nicholl J. Why, and how, mixed methods research is undertaken in health services research in England: a mixed methods study. BMC Health Serv Res 2007; 7: 85.
    • (2007) BMC Health Serv Res , vol.7 , pp. 85
    • O'Cathain, A.1    Murphy, E.2    Nicholl, J.3
  • 16
    • 52649147608 scopus 로고    scopus 로고
    • Critically appraising qualitative research
    • DOI: 10.1136/bmj.a1035
    • Kuper A, Lingard L, Levinson W. Critically appraising qualitative research. BMJ 2008; 337: a1035. DOI: 10.1136/bmj.a1035
    • (2008) BMJ , vol.337
    • Kuper, A.1    Lingard, L.2    Levinson, W.3
  • 17
    • 84872122624 scopus 로고    scopus 로고
    • Survey Monkey. (accessed 05-01-2011).
    • Survey Monkey. www.surveymonkey.com (accessed 05-01-2011).
  • 18
    • 84872162910 scopus 로고    scopus 로고
    • Dutch National Institute of Public Health and the Environment. Hoe vaak komt diabetes mellitus voor en hoeveel mensen sterven eraan? / (Accessed 05-12-2011).
    • Dutch National Institute of Public Health and the Environment. Hoe vaak komt diabetes mellitus voor en hoeveel mensen sterven eraan? 2011. http://www.nationaalkompas.nl/gezondheid-en-ziekte/ziekten-en-aandoeningen/endocriene-voedings-en-stofwisselingsziekten-en-immuniteitsstoornissen/diabetes-mellitus/omvang/ (Accessed 05-12-2011).
    • (2011)
  • 19
    • 84872162449 scopus 로고    scopus 로고
    • Trends in Beeld. Opleidingsniveau van de Nederlandse bevolking. (Accessed 05-12-2011).
    • Trends in Beeld. Opleidingsniveau van de Nederlandse bevolking. http://www.trendsinbeeld.minocw.nl/grafieken/3_1_2_31.php (Accessed 05-12-2011).
  • 20
    • 0030787122 scopus 로고    scopus 로고
    • Consumer participation in research and health care
    • Liberati A. Consumer participation in research and health care. BMJ 1997; 315(7107): 499.
    • (1997) BMJ , vol.315 , Issue.7107 , pp. 499
    • Liberati, A.1
  • 21
    • 33846120161 scopus 로고    scopus 로고
    • Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience
    • Blenkinsopp A, Wilkie P, Wang M, et al. Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2007; 63(2): 148-56.
    • (2007) Br J Clin Pharmacol , vol.63 , Issue.2 , pp. 148-156
    • Blenkinsopp, A.1    Wilkie, P.2    Wang, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.